Does ILOPROST Cause Concomitant disease aggravated? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Concomitant disease aggravated have been filed in association with ILOPROST (AURLUMYN). This represents 0.4% of all adverse event reports for ILOPROST.
22
Reports of Concomitant disease aggravated with ILOPROST
0.4%
of all ILOPROST reports
13
Deaths
15
Hospitalizations
How Dangerous Is Concomitant disease aggravated From ILOPROST?
Of the 22 reports, 13 (59.1%) resulted in death, 15 (68.2%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Concomitant disease aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Concomitant disease aggravated?
SACUBITRIL\VALSARTAN (533)
SECUKINUMAB (461)
FINGOLIMOD (425)
MACITENTAN (286)
OMALIZUMAB (186)
SELEXIPAG (166)
METHOTREXATE (150)
RUXOLITINIB (142)
OCTREOTIDE (125)
BOSENTAN (123)
Which ILOPROST Alternatives Have Lower Concomitant disease aggravated Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT